Healthcare

passed both · New Jersey · Senate Jun 30, 2026

S 4193: Establishes "Fortifying Corn Masa Act."

This bill requires all corn masa flour and wet corn masa products sold in New Jersey to be fortified with folic acid to help reduce the risk of neural tube defects, which disproportionately affect Latino communities. Manufacturers must add specific amounts of folic acid to dry flour and wet products and clearly label these ingredients on nutrition facts panels. The law allows the state health commissioner to grant exemptions for specific products or companies if necessary. By making these changes, the legislation aims to ensure that dietary staples common in Central and South American cuisines provide essential nutritional benefits comparable to other fortified grains.

Topics ✓ HealthcareSupports HealthcareBill mandates folic acid fortification to reduce neural tube defects, directly improving public health outcomes and protecting vulnerable communities.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 30, 2026

A 5062: Requires health insurance and Medicaid coverage for testing and treatments to slow progression of Alzheimer's disease and related disorders.

This New Jersey bill mandates that health insurance plans and Medicaid cover medically necessary tests and FDA-approved treatments designed to slow the progression of Alzheimer's disease and related disorders. The law applies to hospital service, medical service, and health service corporation contracts, as well as individual and group health insurance policies issued or renewed in the state. A key provision ensures that these specific Alzheimer's treatments are not subject to step therapy requirements, meaning patients can access them without needing to try other medications first. Additionally, the coverage must be provided at the same level as benefits for other medical conditions.

Topics ✓ HealthcareSupports HealthcareBill mandates insurance coverage for Alzheimer's treatments, expanding access and protecting patient rights.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

signed · New Jersey · Senate Jun 30, 2026

S 3947: Extends certain pay parity regarding telemedicine and telehealth.*

This bill permanently extends pay parity for telemedicine and telehealth services in New Jersey, requiring health insurance carriers to reimburse providers at the same rates as in-person care. It directly affects insurance companies, healthcare providers, and patients by mandating that out-of-pocket costs like deductibles and copayments for virtual visits cannot exceed those for in-person appointments. The legislation also prohibits insurers from restricting telehealth platforms, limiting service locations, or denying coverage for routine remote monitoring if the same care would be covered in person. Additionally, carriers must continue to allow patients to choose between in-person and virtual care rather than forcing telehealth as a substitute.

Topics ✓ HealthcareSupports HealthcareBill mandates equal reimbursement rates for telehealth and in-person care, improving patient access and protecting healthcare provider compensation.95% confidence ✓ TechnologySupports TechnologyBill promotes digital equity by ensuring telehealth services receive equal reimbursement, expanding access to virtual healthcare and supporting technology adoption in medical services.85% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

passed · New Jersey · General Assembly Jun 30, 2026

A 3434: Creates "New Jersey Dialysis Patient Support Person Accommodation Act."

This bill (A 3434) requires New Jersey dialysis centers to allow patients receiving treatment to be accompanied by a designated support person who can assist with communication, mobility, and care decisions. It directly affects dialysis patients and the centers providing their treatment. Centers must create and display clear written policies for support person access, implement reasonable health/safety rules (without unnecessary restrictions), and train staff on these policies. The New Jersey Department of Health will enforce the law, investigate complaints about denied access, and impose penalties for non-compliance. The law takes effect immediately upon passage.

Topics ✓ HealthcareSupports HealthcareMandates dialysis centers to allow support persons for communication, mobility, and care decisions, directly improving patient access and rights in healthcare services.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 30, 2026

A 2550: Requires continuation of health benefits dependent coverage for certain children with disabilities who are 26 years of age or older.

This bill requires health insurance plans in New Jersey to continue covering adult children with disabilities who are 26 or older, provided they cannot work due to a physical or intellectual disability and are financially dependent on their parent. It amends existing law to extend coverage beyond the standard age limit of 26 for this specific group, ensuring they maintain health insurance through their parent's plan. The bill prohibits denial of coverage based on factors like marriage, having a child, or school status, which commonly affected young adults with disabilities. This change directly impacts young adults with disabilities in New Jersey who would otherwise lose coverage at age 26 but meet the eligibility criteria.

Topics ✓ HealthcareSupports HealthcareExtends mandatory health insurance coverage for disabled adults over 26, ensuring continued access for vulnerable individuals who would otherwise lose benefits at age 26.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 23, 2026

A 1821: Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

This bill prohibits health insurance carriers from denying coverage for nonopioid pain medications in favor of opioids or requiring patients to try opioids first. It requires insurers to treat FDA-approved nonopioid drugs equally to opioids in formularies, meaning coverage restrictions, prior authorization, and cost-sharing tiers must be no more restrictive for nonopioid drugs. The law applies to state health benefit plans, school employee health programs, and Medicaid for acute pain treatment. It takes effect January 1, 2026, directly affecting insurers and patients covered by these plans.

Topics ✓ HealthcareSupports HealthcareProhibits insurers from favoring opioids over nonopioid drugs, ensuring equal coverage and access to alternative pain treatments under state plans and Medicaid.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 23, 2026

A 1207: Requires unrestricted Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill would require New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services without restrictions for beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who seek infertility treatment. The key provision amends Medicaid law to explicitly include these services as a standard benefit, removing prior authorization requirements. This change would expand current coverage to ensure these treatments are accessible as routine care for eligible individuals.

Topics ✓ HealthcareSupports HealthcareExpands Medicaid coverage for infertility treatments by removing prior authorization, improving access to reproductive healthcare services.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 18, 2026

A 1142: Expands requirements for health insurance carriers concerning prostate cancer screening. *

This bill expands New Jersey's existing requirement for health insurance plans to cover prostate cancer screenings without any out-of-pocket costs. It specifically requires coverage for annual screenings - including digital rectal exams and PSA tests - for men aged 50 and older (asymptomatic) and men aged 40 and older with a family history of prostate cancer or other risk factors. The law applies to most health insurance plans, including high-deductible plans where permitted by federal law, and mandates coverage "to the same extent as for any other medical condition." It does not alter existing coverage for other preventive services but ensures no cost-sharing (like deductibles or copays) applies to these specific screenings.

Topics ✓ HealthcareSupports HealthcareExpands mandatory coverage for prostate cancer screenings without cost sharing, increasing patient access to preventive care as required by law.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

in committee · New Jersey · General Assembly Jun 18, 2026

A 2001: Establishes pharmacist licensing exemption for certain dialysis-related drugs and devices.

This bill exempts drug manufacturers and distributors from New Jersey's pharmacy licensing requirements when distributing dialysate drugs and devices used for home dialysis treatment of end-stage renal disease patients. It directly affects dialysis manufacturers, distributors, and patients receiving home dialysis, allowing them to bypass standard pharmacy licensing rules under six specific conditions. Key provisions include requiring FDA approval, direct delivery only upon physician orders, original sealed packaging, and mandatory weekly quality checks by a consultant pharmacist. The law ensures these products are handled safely while streamlining access for patients needing home dialysis.

Topics ✓ HealthcareSupports HealthcareExempts manufacturers/distributors from pharmacy licensing for dialysis drugs, improving patient access to home dialysis by reducing regulatory barriers for essential end-stage renal disease treatment.95% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track

passed · New Jersey · General Assembly Jun 11, 2026

A 5059: Establishes crime of fertility fraud.

This New Jersey bill creates a new crime called fertility fraud, which specifically targets licensed health care practitioners who knowingly use a patient's reproductive material without their written consent. Under the law, a practitioner commits this offense if they use their own sperm or eggs or the material of another person to cause a pregnancy without the patient's informed agreement. If convicted of this third-degree crime, the individual faces up to five years in prison, a fine of $15,000, and the mandatory permanent revocation of their medical license. Additionally, the legislation extends the statute of limitations for prosecuting this specific offense to 20 years from the date of the treatment or 10 years from when the victim discovers the fraud, whichever is later.

Topics ✓ Criminal JusticeSupports Criminal JusticeBill creates a new crime to protect victims of fertility fraud, enhancing legal accountability and justice for reproductive rights violations.90% confidence ✓ HealthcareSupports HealthcareBill protects patient rights by criminalizing unauthorized use of reproductive material, strengthening trust in healthcare providers.90% confidence | Rep's Stance ✓ Voted Yes ✓ Supports Healthcare

Track